doi: 10.1161/hs1001.097097
(Stroke. 2001;32:2299.)
© 2001 American Heart Association, Inc.
Original Contributions |
Effect of Antiplatelet and Anticoagulant Agents on Risk of Hospitalization for Bleeding Among a Population of Elderly Nursing Home Stroke Survivors
From the Department of Community Health (B.J.Q., V.M., K.L.L.) and Center for Gerontology and Health Care Research (K.L.L., V.M.), Brown University, Providence; and School of Medicine, Department of Family Medicine (C.B.E.), Brown University, Pawtucket, RI.
Correspondence to Kate L. Lapane, PhD, Center for Gerontology and Healthcare Research, Brown University, Box G-B222, Providence, RI 02912. E-mail Kate_Lapane{at}brown.edu
Background and Purpose—— Anticoagulants and antiplatelet agents are underutilized in the nursing home setting, perhaps because trials demonstrating treatment efficacy excluded people resembling those with long-term care needs. We sought to quantify the effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among an elderly nursing home population.
Methods—— We used a case-control design and identified first hospitalizations for bleeds using Medicare claims data from 1992 to 1997 as potential cases. Cases had at least one minimum data set (MDS) assessment within the 6 months before that hospitalization and a diagnosis of stroke. We identified up to 5 controls residing in the same facility during the same year and quarter as the case with a diagnosis of stroke. Our sample consisted of 3433 cases and 13 506 controls. Using the MDS, we identified standing orders for aspirin, dipyridamole, ticlopidine, or warfarin and used conditional logistic regression modeling to estimate the effect of these agents on risk of hospitalization for a bleed.
Results—— After adjustment, use of warfarin (odds ratio [OR], 1.26; 95% CI, 1.11 to 1.43) and combination therapy (OR, 1.34; 95% CI, 0.99 to 1.82) were associated with an increased risk of hospitalization for a bleed compared with nonusers. The odds of aspirin use was greater among cases than controls (OR, 1.07; 95% CI, 0.96 to 1.18) after adjustment.
Conclusions—— Although present, the risk associated with use of these agents is small. The numbers needed to treat to harm 1 resident with aspirin and warfarin were 467 and 126, respectively.
Key Words: anticoagulants • antiplatelet agents • case-control studies • cerebellar hemorrhage • gastrointestinal hemorrhage • nursing homes • stroke
This article has been cited by other articles:
 |
|
 |
|
  R. M. Holt, F. L. Schwartz, and J. H. Shubrook Diabetes Care in Extended-Care Facilities: Appropriate intensity of care? Diabetes Care, June 1, 2007; 30(6): 1454 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. I. Shireman, J. D. Mahnken, P. A. Howard, T. F. Kresowik, Q. Hou, and E. F. Ellerbeck Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest, November 1, 2006; 130(5): 1390 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. Papanikolaou, G. D. Christidi, and J. P.A. Ioannidis Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies Can. Med. Assoc. J., February 28, 2006; 174(5): 635 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Christian, K. L. Lapane, and R. S. Toppa Racial Disparities in Receipt of Secondary Stroke Prevention Agents Among US Nursing Home Residents Stroke, November 1, 2003; 34(11): 2693 - 2697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Bjerre, J. LeLorier, B. J. Quilliam, and K. L. Lapane Timeless * Response Stroke, July 1, 2002; 33(7): 1743 - 1744. [Full Text]
|
|